Zoltan Lohinai

Zoltan Lohinai

UNVERIFIED PROFILE

Are you Zoltan Lohinai?   Register this Author

Register author
Zoltan Lohinai

Zoltan Lohinai

Publications by authors named "Zoltan Lohinai"

Are you Zoltan Lohinai?   Register this Author

11Publications

222Reads

-Profile Views

Tumor necrosis correlates with PD-L1 and PD-1 expression in lung adenocarcinoma.

Acta Oncol 2019 Apr 19:1-8. Epub 2019 Apr 19.

b 2nd Department of Pathology, MTA-SE NAP Brain Metastasis Research Group Hungarian Academy of Sciences , Semmelweis University , Budapest , Hungary.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/0284186X.2019.1
Publisher Site
http://dx.doi.org/10.1080/0284186X.2019.1598575DOI Listing
April 2019

Prophylactic cranial irradiation in small-cell lung cancer.

Lancet Oncol 2017 07;18(7):e367

Department of Tumor Biology, National Koranyi Institute of Pulmonology, H-1121, Budapest, Hungary. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30405-9DOI Listing
July 2017

High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma.

Oncotarget 2016 Mar;7(12):13388-99

Translational Thoracic Oncology Laboratory, Division of Thoracic Surgery, Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.7796DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924649PMC
March 2016

Differences in the Epidemiology of Rare EGFR Mutations in Different Populations.

J Thorac Oncol 2016 Jan;11(1):e19-20

Translational Thoracic Oncology Laboratory, Division of Thoracic Surgery, Department of Surgery, Comprehensive Cancer Center, Medical University of Vienna, Austria; 2nd Department of Pathology, Semmelweis University, Budapest, Hungary; Molecular Oncology Research Group, Hungarian Academy of Sciences-Semmelweis University, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2015.09.003DOI Listing
January 2016

Reply to Rare Versus Artifactual EGFR Mutations.

J Thorac Oncol 2015 Aug;10(8):e80-1

National Koranyi Institute of Pulmonology, Budapest, Hungary, Translational Thoracic Oncology Laboratory, Division of Thoracic Surgery, Department of Surgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria, Department of Thoracic Surgery, National Institute of Oncology-Semmelweis University, Budapest, Hungary National Koranyi Institute of Pulmonology, Budapest, Hungary National Koranyi Institute of Pulmonology, Budapest, Hungary, Department of Thoracic Surgery, National Institute of Oncology-Semmelweis University, Budapest, Hungary National Koranyi Institute of Pulmonology, Budapest, Hungary, Translational Thoracic Oncology Laboratory, Division of Thoracic Surgery, Department of Surgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria, Department of Thoracic Surgery, National Institute of Oncology-Semmelweis University, Budapest, Hungary Translational Thoracic Oncology Laboratory, Division of Thoracic Surgery, Department of Surgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria, 2nd Department of Pathology, Semmelweis University, Budapest, Hungary, Molecular Oncology Research Group, Hungarian Academy of Sciences-Semmelweis University, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000591DOI Listing
August 2015

Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung Adenocarcinoma.

J Thorac Oncol 2015 May;10(5):738-46

*Department of Tumor Biology, National Koranyi Institute of Pulmonology, Budapest, Hungary; †Translational Thoracic Oncology Laboratory, Division of Thoracic Surgery, Department of Surgery, Comprehensive Cancer Center, Medical University of Vienna, Austria; ‡Department of Thoracic Surgery, National Institute of Oncology-Semmelweis University; §Department of Pulmonology, ‖Second Department of Pathology, Semmelweis University; ¶Molecular Oncology Research Group, Hungarian Academy of Sciences-Semmelweis University, Budapest, Hungary; #First Department of Pathology, Experimental Cancer Research, Semmelweis University, Budapest, Hungary; and ** Department of Internal Medicine I, Institute of Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000492DOI Listing
May 2015

Subtype-specific KRAS mutations in advanced lung adenocarcinoma: a retrospective study of patients treated with platinum-based chemotherapy.

Eur J Cancer 2014 Jul 22;50(10):1819-1828. Epub 2014 Apr 22.

Department of Tumor Biology, National Koranyi Institute of Pulmonology, Budapest, Hungary; Division of Thoracic Surgery, Medical University of Vienna, Austria; Department of Thoracic Surgery, National Institute of Oncology-Semmelweis University, Budapest, Hungary. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2014.04.001DOI Listing
July 2014